Early Change in Platelet Count and MPV Levels of Patients Who Received Hemodialysis for the First Time: Mogadishu

Oznur Sari1, Ahmed Muhammad Bashir2

  • 1Department of Internal Medicine, Department of Health Services, General Directorate of Public Hospitals, Ministry of Health, Ankara, Turkey.

Abstract

Insights

Mean platelet volume (MPV) and MPV/PLT levels significantly increased after the fourth hemodialysis (HD) session in CKD patients. This suggests increased platelet reactivity early in HD, potentially aiding cardiovascular disease prevention.

Area of Science:

  • Nephrology
  • Hematology
  • Biochemistry

Background:

  • Mean platelet volume (MPV) is a key indicator of platelet size, reactivity, and prothrombotic potential.
  • Platelet indices are increasingly recognized as important markers in various clinical conditions, including chronic kidney disease (CKD).

Purpose of the Study:

  • To investigate the relationship between MPV and biochemical parameters in patients undergoing their first hemodialysis (HD) sessions.
  • To assess changes in MPV and related markers after the fourth HD session compared to the first.

Main Methods:

  • 151 patients undergoing their first HD session were enrolled.
  • Blood samples were collected before the first and after the fourth HD sessions.
  • MPV, platelet count (PLT), and other biochemical parameters were measured.

Main Results:

  • MPV, MPV/PLT, and Sodium (Na) levels showed a significant increase after the fourth HD session compared to the first (p < 0.001).
  • Age and gender were considered, revealing weak positive correlations between MPV and white blood cell count (WBC), neutrophil, and red cell distribution width (RDW).
  • A weak negative correlation was observed between MPV and the platelet-to-lymphocyte ratio (PLR) (p < 0.001).

Conclusions:

  • A significant increase in MPV and MPV/PLT levels was observed in CKD patients by the fourth HD session.
  • Findings suggest a potential increase in platelet reactivity during the initial weeks of HD.
  • This elevation in platelet reactivity may serve as an early marker for cardiovascular disease prevention in HD patients.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
124
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
168
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
270